Total Payments
$284,051
2024 Payments
$10,076
Companies
59
Transactions
940
Medicare Patients
3,106
Medicare Billing
$413,874
Payment Breakdown by Category
Consulting$201,412 (70.9%)
Other$51,790 (18.2%)
Travel$16,477 (5.8%)
Food & Beverage$11,714 (4.1%)
Education$2,657 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $201,412 | 61 | 70.9% |
| Honoraria | $30,000 | 12 | 10.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,665 | 9 | 7.3% |
| Travel and Lodging | $16,477 | 33 | 5.8% |
| Food and Beverage | $11,714 | 784 | 4.1% |
| Education | $2,657 | 40 | 0.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,125 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Foundation Medicine, Inc. | $160,909 | 58 | $0 (2022) |
| G1 Therapeutics, Inc. | $35,960 | 35 | $0 (2023) |
| F. Hoffmann-La Roche AG | $29,310 | 11 | $0 (2024) |
| ARRAY BIOPHARMA INC | $24,412 | 33 | $0 (2024) |
| Celgene Corporation | $8,490 | 45 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $5,204 | 22 | $0 (2024) |
| Epizyme, Inc., | $3,632 | 7 | $0 (2021) |
| Exelixis Inc. | $3,384 | 14 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $1,482 | 121 | $0 (2024) |
| PFIZER INC. | $1,325 | 71 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,076 | 103 | F. Hoffmann-La Roche AG ($7,410) |
| 2023 | $47,850 | 161 | G1 Therapeutics, Inc. ($35,943) |
| 2022 | $63,981 | 165 | Foundation Medicine, Inc. ($48,848) |
| 2021 | $44,023 | 78 | Foundation Medicine, Inc. ($42,500) |
| 2020 | $48,035 | 92 | Foundation Medicine, Inc. ($40,351) |
| 2019 | $48,612 | 142 | Foundation Medicine, Inc. ($26,337) |
| 2018 | $3,874 | 93 | Foundation Medicine, Inc. ($2,838) |
| 2017 | $17,600 | 106 | Celgene Corporation ($8,051) |
All Payment Transactions
940 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $15.10 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $23.51 | General |
| Category: Hematology | ||||||
| 11/18/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Oncology | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: Oncology | ||||||
| 11/13/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Celgene Corporation | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $5.23 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $60.64 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Oncology | ||||||
| 10/01/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $1,710.00 | General |
| 09/30/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Iron Deficiency Anemia | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Oncology | ||||||
| 09/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 643 | 1,160 | $436,525 | $73,672 |
| 2022 | 8 | 771 | 1,378 | $245,979 | $89,278 |
| 2021 | 8 | 961 | 1,833 | $281,539 | $108,358 |
| 2020 | 3 | 731 | 2,248 | $438,146 | $142,567 |
Total Patients
3,106
Total Services
6,619
Medicare Billing
$413,874
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 222 | 533 | $236,889 | $38,708 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 272 | 454 | $130,044 | $21,803 | 16.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 54 | 74 | $8,537 | $3,660 | 42.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 25 | 25 | $31,672 | $3,447 | 10.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 27 | 28 | $18,598 | $3,054 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 24 | 24 | $8,873 | $2,435 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 19 | 22 | $1,912 | $564.20 | 29.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 258 | 670 | $135,507 | $49,787 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 271 | 439 | $57,386 | $21,015 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 75 | 75 | $24,843 | $7,695 | 31.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 26 | 26 | $11,084 | $3,734 | 33.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 21 | $5,931 | $2,439 | 41.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 52 | 59 | $3,924 | $1,580 | 40.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 25 | 30 | $3,458 | $1,577 | 45.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 45 | 58 | $3,846 | $1,451 | 37.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 283 | 712 | $139,080 | $52,011 | 37.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 322 | 594 | $74,467 | $30,821 | 41.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 180 | 340 | $21,579 | $9,341 | 43.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 51 | 51 | $21,233 | $7,449 | 35.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 36 | 36 | $11,505 | $3,699 | 32.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 18 | $4,934 | $2,102 | 42.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 35 | 43 | $5,848 | $1,868 | 31.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 36 | 39 | $2,893 | $1,068 | 36.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 485 | 1,966 | $367,176 | $119,834 | 32.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 123 | 123 | $49,024 | $16,425 | 33.5% |
About Dr. Abdur Shakir, MD
Dr. Abdur Shakir, MD is a Hematology & Oncology healthcare provider based in Mattoon, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669583431.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdur Shakir, MD has received a total of $284,051 in payments from pharmaceutical and medical device companies, with $10,076 received in 2024. These payments were reported across 940 transactions from 59 companies. The most common payment nature is "Consulting Fee" ($201,412).
As a Medicare-enrolled provider, Shakir has provided services to 3,106 Medicare beneficiaries, totaling 6,619 services with total Medicare billing of $413,874. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology, Internal Medicine
- Location Mattoon, IL
- Active Since 08/31/2006
- Last Updated 01/07/2019
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1669583431
Products in Payments
- FOUNDATIONONE CDX (Device) $122,048
- FOUNDATIONONE LIQUID (Device) $38,685
- COSELA (Drug) $35,960
- Braftovi (Drug) $21,102
- Revlimid (Drug) $8,024
- Xofigo (Drug) $5,025
- TAZVERIK (Drug) $3,632
- Cabometyx (Drug) $3,384
- BRAFTOVI (Drug) $3,288
- KEYTRUDA (Biological) $854.41
- IMBRUVICA (Drug) $608.80
- DAURISMO (Drug) $600.00
- KISQALI (Drug) $407.85
- LYNPARZA (Drug) $343.95
- CYRAMZA (Drug) $343.94
- VENCLEXTA (Drug) $329.65
- DARZALEX (Biological) $300.31
- PROMACTA (Drug) $289.67
- Zydelig (Drug) $250.00
- Lenvima (Drug) $237.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Mattoon
Kuppuswamy Jagarlamudi, M.d, M.D
Hematology & Oncology — Payments: $17,361
Hematology & Oncology $17,361
Dr. Musaberk Goksel, M.d, M.D
Hematology & Oncology — Payments: $4,077
Hematology & Oncology $4,077
Edward Hoppin, M.d, M.D
Hematology & Oncology
Hematology & Oncology
John Schmale, Md, MD
Hematology & Oncology
Hematology & Oncology